Sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studies.
二型糖尿病中的鈉葡萄糖共同轉運蛋白2抑制劑:心臟衰竭臨床試驗效益在實際臨床實踐中有體現嗎?觀察性研究的系統性回顧和荟萃分析。
Diabetes Obes Metab 2023-01-31
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials.
糖尿病對鈉葡萄糖共同轉運蛋白-2抑制劑對腎臟結果影響的合作性大型安慰劑對照試驗的荟萃分析。
Lancet 2023-08-16
SGLT2 inhibitors reduce adverse renal and CV outcomes in patients with or without diabetes.
SGLT2 抑制劑可降低糖尿病患者及非糖尿病患者的不良腎臟和心血管結果。
Ann Intern Med 2023-03-23
New-onset diabetes with sodium-glucose cotransporter-2 inhibitors in prediabetes: An updated meta-analysis and possible mechanisms.
使用鈉葡萄糖共轉運輸蛋白-2抑制劑治療糖尿病前期的新發糖尿病:更新的荟萃分析及可能機制。
Diabetes Metab Syndr 2023-07-07
Differential effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose-response meta-analysis involving 10 randomized clinical trials and 71 553 individuals.
腎功能不同對鈉葡萄糖共轉運蛋白2抑制劑在心血管和腎臟結果上的差異影響:涉及10個隨機臨床試驗和71,553名個體的劑量反應荟萃分析。
Eur J Endocrinol 2023-08-04
Cardiovascular Outcomes of Sodium-Glucose Cotransporter-2 Inhibitors Therapy in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Updated Meta-Analysis.
二型糖尿病合併慢性腎臟病患者接受鈉葡萄糖共同轉運蛋白2抑制劑治療的心血管結果:系統性回顧與更新的荟萃分析。
Korean Circ J 2024-06-11
Sodium-glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real-world, cohort data.
鈉-葡萄糖共轉運蛋白 2 抑制劑降低心衰竭無糖尿病患者發生 2 型糖尿病的風險:一項真實世界隊列數據的分析。
Diabetes Obes Metab 2024-08-07
Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Heart Failure in Patients With Type 2 Diabetes Mellitus: A Systematic Review.
鈉-葡萄糖共轉運蛋白-2 抑制劑對於2型糖尿病患者心臟衰竭的影響:系統性回顧。
Cureus 2024-10-04